Standardized methods to quantify thrombogenicity of blood-contacting materials via thromboelastography

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 1, 2012, Pages 230-238

  Shankarraman, Venkat ^a   Davis Gorman, Grace ^b   Copeland, Jack G ^b   Caplan, Michael R ^a   McDonagh, Paul F ^b  

^a Arizona State University   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

biocompatible materials; blood coagulation; endothelial cells; thromboelastogram; vascular graft

Indexed keywords

BIOCOMPATIBLE MATERIALS; BIOMATERIAL SURFACES; BLOOD COAGULATION; CLAMPED ENDS; CLINICAL SETTINGS; CLOT FORMATION; EXPANDED POLY(TETRAFLUOROETHYLENE); EXTRACELLULAR MATRIX PROTEIN; HEMOCOMPATIBILITY; IN-VITRO; PROTEOGLYCANS; SAMPLE PREPARATION; STANDARDIZED METHODS; TECHNIQUES USED; THROMBOELASTOGRAM; THROMBOGENICITY; VASCULAR GRAFTS; WHOLE BLOOD;

BIOLOGICAL MATERIALS; BLOOD; COAGULATION; ENDOTHELIAL CELLS; GRAFTS; POLYTETRAFLUOROETHYLENES; PROTEINS;

BIOMATERIALS;

BIOMATERIAL; POLITEF; POLYURETHAN;

ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; POLITEF IMPLANT; SHEAR STRESS; THROMBOELASTOGRAPHY; THROMBOGENICITY; UMBILICAL VEIN ENDOTHELIAL CELL;

BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; BLOOD VESSEL PROSTHESIS; CELLS, CULTURED; HUMANS; MATERIALS TESTING; POLYTETRAFLUOROETHYLENE; POLYURETHANES; THROMBELASTOGRAPHY;

EID: 82955203711     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31942     Document Type: Article

References (43)

1. Nelson GN, Mirensky T, Brennan MP, Roh JD, Yi T, Wang Y, Breuer CK,. Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings. Arch Surg 2008; 143: 488-494. (Pubitemid 351717442)
2. Ravi S, Chaikof EL,. Biomaterials for vascular tissue engineering. Regen Med; 2010; 5: 107-120.
3. Gorbet MB, Sefton MV,. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004; 25: 5681-5703. (Pubitemid 38624449)
4. Murugesan S, Park TJ, Yang H, Mousa S, Linhardt RJ,. Blood compatible carbon nanotubes-nano-based neoproteoglycans. Langmuir 2006; 22: 3461-3463. (Pubitemid 43672508)
5. Kainthan RK, Hester SR, Levin E, Devine DV, Brooks DE,. In vitro biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 2007; 28: 4581-4590. (Pubitemid 47259174)
6. Lippi G, Favaloro EJ,. Activated partial thromboplastin time: new tricks for an old dogma. Semin Thromb Hemost 2008; 34: 604-611.
7. Davidson GW III, Peppas NA, Thornhill JA, Ash SR,. Assessment of biomaterials as components of a reciprocating dialyser during canine dialysis. Biomaterials 1984; 5: 227-233. (Pubitemid 14046077)
8. Liu WG, Zhang JR, Cao ZQ, Xu FY, Yao KD,. A chitosan-arginine conjugate as a novel anticoagulation biomaterial. J Mater Sci Mater Med 2004; 15: 1199-1203.
9. Ye SH, Johnson CA Jr, Woolley JR, Oh HI, Gamble LJ, Ishihara K, Wagner WR,. Surface modification of a titanium alloy with a phospholipid polymer prepared by a plasma-induced grafting technique to improve surface thromboresistance. Colloids Surf B Biointerfaces 2009; 74: 96-102.
10. Ye SH, Johnson CA Jr, Woolley JR, Snyder TA, Gamble LJ, Wagner WR,. Covalent surface modification of a titanium alloy with a phosphorylcholine- containing copolymer for reduced thrombogenicity in cardiovascular devices. J Biomed Mater Res A 2009; 91: 18-28.
11. Prasad CK, Muraleedharan CV, Krishnan LK,. Bio-mimetic composite matrix that promotes endothelial cell growth for modification of biomaterial surface. J Biomed Mater Res A 2007; 80: 644-654. (Pubitemid 46239076)
12. Snyder TA, Tsukui H, Kihara S, Akimoto T, Litwak KN, Kameneva MV, Yamazaki K, Wagner WR,. Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation. J Biomed Mater Res A 2007; 81: 85-92. (Pubitemid 46435456)
13. Peng HT,. Thromboelastographic study of biomaterials. J Biomed Mater Res B Appl Biomater 2010; 94B: 469-485.
14. Copeland JG III,. Thromboembolism and bleeding: clinical strategies. Ann Thorac Surg 1996; 61: 376-377; discussion 378-379.
15. Bird RL, Hall B, Hobbs KE, Chapman D,. New haemocompatible polymers assessed by thrombelastography. J Biomed Eng 1989; 11: 231-234. (Pubitemid 19110709)
16. Bird RR, Hall B, Chapman D, Hobbs KE,. Material thrombelastography: an assessment of phosphorylcholine compounds as models for biomaterials. Thromb Res 1988; 51: 471-483.
17. Mortier E, Ongenae M, De Baerdemaeker L, Herregods L, Den Blauwen N, Van Aken J, Rolly G,. In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography. Anaesthesia 1997; 52: 1061-1064. (Pubitemid 27487467)
18. Niemi TT, Kuitunen AH,. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005; 49: 373-378. (Pubitemid 40432532)
19. Lee DW, Baney RH,. Oligochitosan derivatives bearing electron-deficient aromatic rings for adsorption of amitriptyline: implications for drug detoxification. Biomacromolecules 2004; 5: 1310-1315. (Pubitemid 39089730)
20. Senzolo M, Coppell J, Cholongitas E, Riddell A, Triantos CK, Perry D, Burroughs AK,. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis 2007; 18: 227-236. (Pubitemid 46597394)
21. Lee D-W, Powers K, Baney R,. Physicochemical properties and blood compatibility of acylated chitosan nanoparticles. Carbohyd Polym 2004; 58: 371-377.
22. Morey TE, Varshney M, Flint JA, Seubert CN, Smith WB, Bjoraker DG, Shah DO, Dennis DM,. Activity of microemulsion-based nanoparticles at the human bio-nano interface: Concentration dependent effects on thrombosis and hemolysis in whole blood. J Nanopart Res 2004; 6: 159-170.
23. Murugesan S, Mousa S, Vijayaraghavan A, Ajayan PM, Linhardt RJ,. Ionic liquid-derived blood-compatible composite membranes for kidney dialysis. J Biomed Mater Res B Appl Biomater 2006; 79: 298-304. (Pubitemid 44652055)
24. Valeri CR, Srey R, Tilahun D, Ragno G,. In vitro effects of poly-N-acetyl glucosamine on the activation of platelets in platelet-rich plasma with and without red blood cells. J Trauma 2004; 57 (1 Suppl): S22-S25; discussion S25. (Pubitemid 39079213)
25. Fischer TH, Bode AP, Demcheva M, Vournakis JN,. Hemostatic properties of glucosamine-based materials. J Biomed Mater Res A 2007; 80: 167-174. (Pubitemid 44913344)
26. Peng HT, Blostein MD, Shek PN,. Experimental optimization of an in situ forming hydrogel for hemorrhage control. J Biomed Mater Res B Appl Biomater 2009; 89: 199-209.
27. Chepurov AK, Belomestnaia ZM, Donetskii IA, Tsidvintseva GV,. [Thromboresistent properties of hydrophilic gels]. Biull Eksp Biol Med 1980; 89: 296-298.
28. Klocking HP, Schunk W, Merkmann G, Giessmann C, Knoll H, Borgmann S,. A natural rubber drainage tube with antithrombogenic lumen surface. Thromb Res 1993; 72: 501-507. (Pubitemid 23362358)
29. Chevallier P, Janvier R, Mantovani D, Laroche G,. In vitro biological performances of phosphorylcholine-grafted ePTFE prostheses through RFGD plasma techniques. Macromol Biosci 2005; 5: 829-839. (Pubitemid 41360881)
30. Copeland JG, Arabia FA, Smith RG, Sethi GK, Nolan PE, Banchy ME,. Arizona experience with CardioWest Total Artificial Heart bridge to transplantation. Ann Thorac Surg 1999; 68: 756-760. (Pubitemid 29521163)
31. Haemoscope Corporation. TEG 5000 User's Manual. Niles, IL: Haemoscope Corporation; 2002. pp 1-10.
32. Shankarraman V, Shah MM, Caplan MR,. Substrates elicit different patterns of intracellular signaling which in turn cause differences in cell adhesion. Cell Mol Bioeng 2010; 3: 229-246.
33. Courtney JM, Lamba NM, Sundaram S, Forbes CD,. Biomaterials for blood-contacting applications. Biomaterials 1994; 15: 737-744. (Pubitemid 24251989)
34. Bridges AW, Whitmire RE, Singh N, Templeman KL, Babensee JE, Lyon LA, Garcia AJ,. Chronic inflammatory responses to microgel-based implant coatings. J Biomed Mater Res A 2010; 94: 252-258.
35. McGuigan AP, Sefton MV,. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 2007; 28: 2547-2571. (Pubitemid 46371460)
36. Luddington RJ,. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90. (Pubitemid 40515992)
37. Weinberg CB, Bell E,. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231: 397-400. (Pubitemid 16108649)
38. Ravi S, Qu Z, Chaikof EL,. Polymeric materials for tissue engineering of arterial substitutes. Vascular 2009; 17 Suppl 1: S45-S54.
39. Riley JB, Stammers AH,. A Technique to give clinical relevance to parameters from the thromboelastograph. J Extra-Corpor Technol 1992; 23: 112-124.
40. Artang R, Frandsen NJ, Nielsen JD,. Application of basic and composite thrombelastography parameters in monitoring of the antithrombotic effect of the low molecular weight heparin dalteparin: an in vivo study. Thromb J 2009; 7: 14.
41. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, Weg JG,. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119 (1 Suppl): 176S-193S. (Pubitemid 32154199)
42. Kopp R, Bensberg R, Henzler D, Niewels A, Randerath S, Rossaint R, Kuhlen R,. Hemocompatibility of a miniaturized extracorporeal membrane oxygenation and a pumpless interventional lung assist in experimental lung injury. Artif Organs 2010; 34: 13-21.
43. Koster A, Sanger S, Knorig FJ, Kuppe H, Hetzer R, Loebe M,. Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: a pilot investigation in five patients undergoing extended vascular surgery in deep hypothermia. ASAIO J 2002; 48: 106-109. (Pubitemid 34575779)